Topical evidence is stronger and includes IRB-approved human trials
Since then, shortages have ended, and the FDA says [archived link] the non-approved compounded versions can no longer be made and sold
Lu et al., 2014
"More than half of those who stopped restarted therapy within a year (41.5%), and nearly two-thirds did so within two years (58%)," Sontha said
The relationship between milligrams, milliliters, and syringe units works identically for tirzepatide dosing , BPC-157 protocols , and virtually every other reconstituted peptide
Contact your healthcare provider promptly if you develop jaundice (yellowing of skin or eyes), dark-colored urine, pale stools, persistent right upper quadrant abdominal pain, or unexplained severe fatigue